These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8076179)

  • 1. [Molecular genetics in pure primary hypercholesterolemia].
    Benlian P; Dairou F; de Gennes JL
    Bull Acad Natl Med; 1994 Mar; 178(3):393-403; discussion 403-4. PubMed ID: 8076179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects.
    Saint-Jore B; Varret M; Dachet C; Rabès JP; Devillers M; Erlich D; Blanchard P; Krempf M; Mathé D; Chanu B; Jacotot B; Farnier M; Bonaïti-Péllié C; Junien C; Boileau C
    Eur J Hum Genet; 2000 Aug; 8(8):621-30. PubMed ID: 10952765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Familial hypercholesterolemia].
    Turpin G; Bruckert E
    Ann Med Interne (Paris); 1999 Dec; 150(8):605-14. PubMed ID: 10686642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders.
    Pullinger CR; Kane JP; Malloy MJ
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):107-19. PubMed ID: 15030301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal recessive hypercholesterolemia in three sisters with phenotypic homozygous familial hypercholesterolemia: diagnostic and therapeutic procedures.
    Thomas HP; Vogt A; Wilund KR; Schliesser C; Steinhagen-Thiessen E; Kassner U
    Ther Apher Dial; 2004 Aug; 8(4):275-80. PubMed ID: 15274677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.
    Civeira F; Ros E; Jarauta E; Plana N; Zambon D; Puzo J; Martinez de Esteban JP; Ferrando J; Zabala S; Almagro F; Gimeno JA; Masana L; Pocovi M
    Am J Cardiol; 2008 Nov; 102(9):1187-93, 1193.e1. PubMed ID: 18940289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular genetic causes of familial hypercholesterolemia].
    Leren TP
    Tidsskr Nor Laegeforen; 1993 Oct; 113(26):3251-4. PubMed ID: 8236220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia.
    Norman D; Sun XM; Bourbon M; Knight BL; Naoumova RP; Soutar AK
    J Clin Invest; 1999 Sep; 104(5):619-28. PubMed ID: 10487776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for mutations in the LDL receptor gene and apolipoprotein B-100 gene in 218 patients with severe hypercholesterolemia.
    Geisel J; Holzem G; Schleifenbaum T; Oette K
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():14-5. PubMed ID: 8767447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of 1053 Danish individuals with clinical signs of familial hypercholesterolemia.
    Brusgaard K; Jordan P; Hansen H; Hansen AB; Hørder M
    Clin Genet; 2006 Mar; 69(3):277-83. PubMed ID: 16542394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
    Wang J; Huff E; Janecka L; Hegele RA
    Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two novel LDL receptor gene defects in French-Canadian pediatric population: mutational analysis and biochemical studies.
    Assouline L; Leitersdorf E; Lambert M; Reshef A; Feoli-Fonseca JC; Levy E
    Hum Mutat; 1997; 9(6):555-62. PubMed ID: 9195230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW; Kastelein JJ; Defesche JC
    Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathobiology of familial hypercholesterolemic atherosclerosis.
    Aliev G; Castellani RJ; Petersen RB; Burnstock G; Perry G; Smith MA
    J Submicrosc Cytol Pathol; 2004; 36(3-4):225-40. PubMed ID: 15906597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic aspects of primary atherogenic dyslipoproteinemia].
    Turpin G; Bruckert E
    C R Seances Soc Biol Fil; 1995; 189(5):905-17. PubMed ID: 8673636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.
    Takada D; Emi M; Ezura Y; Nobe Y; Kawamura K; Iino Y; Katayama Y; Xin Y; Wu LL; Larringa-Shum S; Stephenson SH; Hunt SC; Hopkins PN
    J Hum Genet; 2002; 47(12):656-64. PubMed ID: 12522687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Direct detection of mutations in the LDL receptor gene in patients with familial hypercholesterolemia].
    Freiberger T; Kuhrová V; Kozák L; Soska V; Pekarík V; Mĕrínská L; Fajkusová L; Francová H
    Cas Lek Cesk; 1998 Dec; 137(24):750-2. PubMed ID: 10081189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.